某集团资产负债管理及现金流量财务报表分析

资产负债表、利润表、现金流量表分析——会计151小组现金流量表资产负债表利润表123资产负债表1一、主要工程结构分析流动资产结构图示短期偿债能力短期偿债能力2011年2010年2009年2008年参考标准营运资本-136144.00-107540.00-123026.00-163389.00大于0流动比率76.34%76.40%70.77%60.43%1.5:1速动比率42.11%43.89%44.79%41.12%0.8:1现金比率25.03%28.33%32.62%28.41%财务困境时用长期偿债能力长期偿债能力2011年2010年2009年2008年资产负债率79.61%75.21%72.87%72.91%产权比率390.34%303.38%268.63%269.20%有形净值债务率-4974.83%-26120.61%-20985.34%-2503.62%资产营运效率资产营运效率

2011年

2010年

2009年

2008年

总资产周转率

85.25%88.34%84.47%81.83%流动资产周转率

162.18%185.29%192.71%193.82%应收账款周转率

1307.75%1472.56%1399.55%1364.03%存货周转率

398.36%481.16%518.17%562.29%固定资产周转率

483.32%446.69%381.68%345.23%资产营运效率(天数)

2011年

2010年

2009年

2008年

总资产周转率

422.29407.52426.19439.94流动资产周转率

221.98194.29186.81185.74应收账款周转率

27.5324.4525.7226.39存货周转率

90.3774.8269.4864.02固定资产周转率

74.4880.5994.32104.28利润表2太极集团利润表太极集团利润表_结构百分比同行业利润表_结构百分比代码简称实际流通A股销售净利率%排名002653海思科0.455.591002038双鹭药业3.1354.962002693双成药业0.352.13002393力生制药0.8334.084002437誉衡药业0.9521.485600196复星医药9.8820.296600276恒瑞医药12.3419.917600867通化东宝7.7618.468002422科伦药业2.2317.619000915山大华特1.7914.5110000566海南海药2.3614.2311000513丽珠集团1.7811.8112600080金花股份3.0511.6613002004华邦制药3.1211.414600568中珠控股0.8511.1715600490中科合臣3.310.1816600062华润双鹤5.728.5117600513联环药业1.528.3218000522白云山A4.698.2219002262恩华药业1.967.8620002099海翔药业2.587.6321行业分析-销售净利率代码简称实际流通A股销售净利率%排名600829三精制药5.87.6222000605ST四环0.936.4723600420现代制药2.885.1224600466迪康药业4.394.7725600666西南药业2.94.7626000545ST吉药1.164.2327600380健康元15.464.2328000597东北制药3.313.1529600664哈药股份10.532.1330600222太龙药业4.121.4231000153丰原药业2.311.2132600253天方药业4.19133600129太极集团4.270.4634000606青海明胶3.93-2.0235002370亚太药业0.78-5.1636600421ST国药1.96-10.5637600671ST天目1.22-17.9938600771ST东盛1.66-34.5739600385ST金泰1.43-245.440行业分析-销售净利率〔续〕行业分析–费用控制项目（2008年，%）MAXMINAverage太极集团一、营业总收入100.00%100.00%100.00%100.00%二、营业总成本1600.34%33.54%153.36%98.94%营业成本99.59%13.70%61.47%77.02%营业税金及附加2.27%0.16%0.73%0.60%销售费用52.57%0.56%15.14%10.71%管理费用293.21%2.94%20.78%6.68%财务费用396.94%-1.55%15.66%3.80%资产减值损失1356.68%-26.10%39.58%0.14%公允价值变动收益0.30%-21.54%-1.22%0.00%投资收益38.56%-10.47%2.23%0.01%其中：对联营企业和合营企业的投资收益11.35%-10.47%0.05%0.00%三、营业利润63.97%-1461.78%-52.35%1.07%营业外收入307.82%0.18%13.27%1.35%营业外支出68.96%0.02%3.31%0.72%非流动资产处置损失29.57%0.00%0.79%0.02%利润总额179.12%-1457.17%-42.39%1.71%所得税费用59.94%-1.32%3.04%0.48%四、净利润119.18%-1457.17%-45.43%1.22%行业分析–费用控制项目（2009年，%）MAXMINAverage太极集团一、营业总收入100.00%100.00%100.00%100.00%二、营业总成本306.09%-165.04%94.09%98.54%营业成本101.42%17.17%60.26%74.90%营业税金及附加2.56%0.00%0.83%0.59%销售费用44.55%0.15%15.81%11.86%管理费用176.81%2.89%19.73%8.33%财务费用173.50%-1.74%8.56%2.72%资产减值损失58.95%-472.21%-11.09%0.14%公允价值变动收益7.68%0.00%0.48%0.00%投资收益83.13%-5.77%2.67%0.01%其中：对联营企业和合营企业的投资收益11.43%-5.77%0.33%0.00%三、营业利润265.04%-211.86%9.05%1.47%营业外收入271.46%0.09%10.23%0.71%营业外支出10.78%0.00%0.85%0.12%非流动资产处置损失0.86%0.00%0.11%0.03%利润总额290.95%-122.61%18.44%2.06%所得税费用18.09%-0.13%2.48%0.61%四、净利润289.41%-126.46%15.95%1.46%行业分析–费用控制项目（2010年，%）MAXMINAverage太极集团一、营业总收入100.00%100.00%100.00%100.00%二、营业总成本358.98%42.25%102.62%100.49%营业成本96.28%16.20%59.17%76.04%营业税金及附加5.21%0.02%0.92%0.52%销售费用42.78%0.04%16.24%13.75%管理费用160.99%3.78%16.17%7.46%财务费用151.55%-2.52%7.76%2.57%资产减值损失53.77%-0.76%2.35%0.15%公允价值变动收益1.00%-1.99%-0.01%0.00%投资收益25.94%-6.20%2.02%0.02%其中：对联营企业和合营企业的投资收益12.12%-6.20%0.62%0.00%三、营业利润61.50%-265.18%-0.60%-0.48%营业外收入158.57%0.03%6.67%0.70%营业外支出17.46%0.00%1.07%2.29%非流动资产处置损失7.09%0.00%0.32%0.40%利润总额88.19%-265.18%5.00%-2.07%所得税费用9.98%-0.06%2.07%0.04%四、净利润88.00%-265.18%2.93%-2.12%行业分析–费用控制项目（2011年，%）MAXMINAverage太极集团一、营业总收入100.00%100.00%100.00%100.00%二、营业总成本458.58%40.18%106.84%101.43%营业成本93.70%17.23%59.44%76.79%营业税金及附加2.64%0.16%0.91%0.52%销售费用41.98%0.00%17.09%12.75%管理费用169.26%3.87%17.46%7.45%财务费用178.81%-6.05%6.59%3.78%资产减值损失116.21%-1.14%5.34%0.14%公允价值变动收益0.04%-0.45%-0.04%0.00%投资收益51.79%-3.41%7.06%0.00%其中：对联营企业和合营企业的投资收益35.11%-3.41%1.30%0.00%三、营业利润95.23%-361.99%0.18%-1.43%营业外收入179.28%0.00%7.09%2.95%营业外支出11.63%0.00%0.74%0.22%非流动资产处置损失1.07%0.00%0.08%0.09%利润总额144.54%-364.58%6.54%1.29%所得税费用12.86%0.00%2.51%0.60%四、净利润134.55%-364.58%4.03%0.69%利润表〔简化报表〕盈利能力–销售收入根底盈利能力–本钱费用盈利能力盈利能力–资产根底盈利能力–资本盈利能力增长能力增长能力图示行业分析–

市净率分析代码简称实际流通A股每股净资产(元)

排名121130收盘价市净率排名002262恩华药业1.962.811725.2991600276恒瑞医药12.343.99422427.866.982600671ST天目1.221.133847.786.863002038双鹭药业3.135.01682633.96.764002653海思科0.43.92322.95.875600490中科合臣3.32.761612.954.696600420现代制药2.882.64251411.864.497600666西南药业2.91.576.084.058000915山大华特1.793.32013.249600466迪康药业4.391.2654.313.4210600513联环药业1.522.24107.393.311000513丽珠集团1.789.873532.13.2512600867通化东宝7.762.62138.333.1813600253天方药业4.192.04596.323.0914000606青海明胶3.931.684.552.8415002422科伦药业2.2317.673749.772.8216600222太龙药业4.121.492664.182.817600062华润双鹤5.727.89883320.122.5518行业分析–市净率分析〔续〕代码简称实际流通A股每股净资产(元)

排名121130收盘价市净率排名002004华邦制药3.125.22812.82.4619002099海翔药业2.582.34115.262.2520600129太极集团4.272.7193156.12.2421002693双成药业0.36.873215.32.2322002437誉衡药业0.958.13416.872.0823600080金花股份3.053.1277196.432.0624600829三精制药5.83.5021217.182.0525002370亚太药业0.783.52227.142.0326000153丰原药业2.312.8143185.652.0127002393力生制药0.8315.043630.08228600196复星医药9.885.18279.231.7829600380健康元15.462.5191123.971.5830000566海南海药2.365.5823308.111.4531600664哈药股份10.534.12255.681.3832600568中珠控股0.855.83317.541.2933000597东北制药3.315.252295.681.0834600385ST金泰1.43-1.7424.41-2.5335600771ST东盛1.66-3.0518.61-2.8236600421ST国药1.96-0.8734.37-5.0237行业分析–

市盈率分析代码简称实际流通A股每股收益(元)

排名121130收盘价市盈率排名600222太龙药业4.120.025274.18165.871600466迪康药业4.390.027384.31157.882600253天方药业4.190.0585106.32108.033600490中科合臣3.30.121212.95107.924600129太极集团4.270.057796.1105.725000153丰原药业2.310.0623115.6590.696600420现代制药2.880.22791911.8652.047002262恩华药业1.960.49662625.2950.938600080金花股份3.050.1269146.4350.679600867通化东宝7.760.1702178.3348.9410002437誉衡药业0.950.352216.8748.211600513联环药业1.520.16167.3946.1912600666西南药业2.90.14156.0843.4313600276恒瑞医药12.340.65043127.8642.8414002038双鹭药业3.130.91793333.936.9315600380健康元15.460.1205133.9732.9516002422科伦药业2.231.63749.7731.1117002693双成药业0.30.52715.330.618行业分析–市盈率分析〔续〕代码简称实际流通A股每股收益(元)

排名121130收盘价市盈率排名000915山大华特1.790.472513.228.0919000513丽珠集团1.78